Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while Vanguard Global ex-US Real Estate Index Fd ETF trades at $45.3. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Vanguard Global ex-US Real Estate Index Fd ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | VNQI | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $50.76 |
52-Week Low | $23.09 | $43.26 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
VNQI trades at $45.54, up 0.89% today, but technical indicators signal a bearish trend with moving averages showing sell pressure. The ETF offers broad international real estate exposure with a low 0.12% expense ratio and a 4.6% dividend yield, though it has underperformed domestic peers in total returns over five years. Recent news highlights its role as a diversification tool amid stabilizing global rates.
The outlook is mixed: VNQI provides cost-effective global diversification and income, but faces headwinds from weaker international performance and currency risks. Investors seeking yield and non-U.S. exposure may find value, though near-term technical weakness and competitive pressure from domestic ETFs pose risks to momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard Global ex-US Real Estate Index Fd ETF
The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →
